axogen has acquired BioCircuit Technologies for $200.0M. BioCircuit Technologies, based in Atlanta, GA, is a developer and commercializer of advanced medical devices for tissue repair and neuromodulation. Its first commercial product, Nerve Tape®, is a groundbreaking sutureless device designed for repairing transected nerves. This innovative product enables fast, consistent, and precise repairs, providing high-quality outcomes while simplifying complex procedures for surgeons.
BioCircuit's expertise spans biomaterials, precision nitinol design and manufacturing, and bioelectronics for nerve stimulation and recording. These capabilities have allowed the company to deliver innovative, high-performance solutions to the medical community, with a commitment to expanding its portfolio with products that enhance surgical capabilities and improve patient care.
The acquisition of BioCircuit Technologies by axogen represents a strategic move to integrate BioCircuit's specialized nerve repair technology and product development strengths. This integration is expected to significantly broaden axogen's offerings in the field of regenerative medicine, providing an advanced, sutureless option for nerve repair that addresses a critical need. The addition of Nerve Tape® directly complements axogen's existing focus, aiming to enhance the precision and efficiency of nerve repair procedures for medical professionals and ultimately benefit patients.
The combined organization is now positioned to further advance solutions for nerve repair and regeneration. This integration of technologies and expertise is anticipated to foster continued innovation, ultimately aiming to improve patient outcomes and expand the availability of sophisticated medical devices in the market.